Actuate Therapeutics, Inc.
ACTUBiotechnology
$0.37−3.21%As of Oct 29vs prior close
- Market cap
- $20.4M
- P/E (TTM)
- –
- From 52W high
- −95.14%
- EPS (LTM)
- -$0.88
- Dividend yield
- 0.00%
Nomior Score
21
Steady ProfileSpeculativeBottom 7% of the scored universe
Growth—
Quality36
Value—
Momentum8
Resilience25
Connections
Who owns it
2funds